INTRODUCTION {#S5}
============

In order to maintain adequate substrate for cerebral metabolism, there is a tightly regulated relationship between oxygen extraction, cerebral blood flow, and tissue hemoglobin ([@R1]). Impairment in cerebrovascular autoregulation in the setting of hypotension ([@R2],[@R3]) has been linked to the development of intraventricular hemorrhage (IVH), a potentially devastating form of brain injury in preterm infants, associated with a significantly increased risk for neurodevelopmental impairment ([@R4]--[@R6]).

However, despite preliminary data suggesting that hypotension and impaired autoregulation are correlated ([@R7]) and that rates of brain injury are higher for infants who spend greater proportions of time with a mean arterial blood pressure (MABP) below 30 mmHg ([@R8]), the relationship remains unclear. Further complicating matters is the known association between volume resuscitation ([@R9],[@R10]) and inotropic medications ([@R11],[@R12]) and the development of IVH, generating significant concern for brain injury at both extremes of blood pressure. Indeed, it is the alternating cycles of hypoxic-ischemic and reperfusion that may injure the germinal matrix and set the stage for pathologic hemorrhage ([@R12]).

Recent work by the authors suggest that there is a developmentally-linked component of autoregulatory function---less mature infants demonstrate a more limited ability to adapt fluctuations in systemic blood pressure ([@R13]). Given that there is also a steadily increasing risk in the development of intraventricular hemorrhage, approximately 3% per week of gestation ([@R14],[@R15]), it is reasonable to hypothesize that an immature, poorly functioning cerebrovascular autoregulatory system is a significant contributing factor to the development of IVH. However, as noted by Soul et al., impaired autoregulation is common in preterm infants ([@R7]), even those who do not go on to develop IVH. Taking all of these findings into account, we hypothesize that impaired autoregulation *and* fluctuations in blood pressure are necessary for the development of IVH.

The traditional depiction of the cerebrovascular autoregulatory system is a sigmoidal curve, with stable cerebral blood flow (CBF) across a range of normal blood pressures, decreased CBF during hypotension, and increased CBF during hypertension. CBF is regulated by changes in vascular tone, constantly changing the vessel caliber to maintain adequate cerebral perfusion. A number of vascular control mechanisms have been described, including the myogenic response, marked by constriction or relaxation of the vessels in response to volume-related stretching of the vessels ([@R16]) and autonomic regulation ([@R17]), utilizing the release of vasoactive compounds (such as epinephrine) in response to stimulation of the sympathetic or parasympathetic nervous system. While both of these components of autoregulation are important, there is increasing recognition that cerebral metabolism also plays an important role in the regulation of blood flow ([@R18]). The cerebral metabolic rate of oxygen (CMRO~2~) is the product of oxygen extraction (OE), CBF, and total hemoglobin concentration (HbT), *CMRO~2~ = OE x CBF x \[HbT\]* ([@R1]). Assuming a globally stable CMRO~2~ and \[HbT\] (at least over the short-term), an intact autoregulatory system, seeking to maintain stable cerebral tissue oxygenation, should increase extraction when blood pressure is low (i.e., inadequate oxygen delivery), and decrease extraction when the blood pressure rises.

In this paper, we seek to examine the interaction between variation in blood pressure, changes in oxygen extraction, and developmental maturity. We utilized high-resolution measurement of the arterial blood pressure, pulse oximetry, and cerebral oxygenation (as derived by near-infrared spectroscopy) to evaluate differences in this relationship between a more preterm group (23--25 weeks) and a more mature group (26--28 weeks).

METHODS {#S6}
=======

Cohort selection {#S7}
----------------

Premature infants, born prior to 28 completed week of gestation and admitted to the NICU at St. Louis Children's Hospital, a level IV unit serving an urban, suburban, and rural population, were recruited within the first 24 hours for a prospective, multimodality monitoring study. Infants were excluded if a) there was an antenatal diagnosis of congenital or chromosomal anomaly, b) if an umbilical arterial catheter was not placed, or c) the infant was moribund and not expected to survive through the 72-hour monitoring window. Infants were divided by gestational age at birth into a more preterm group (23--25 weeks) and a more mature group (26--28 weeks). The study protocol and procedures were reviewed and approved by the Human Subjects Research Protection Office at Washington University.

Sample characteristics {#S8}
----------------------

Comprehensive sample characteristics were collected for all included infants. Antenatal factors included mode of delivery, antenatal magnesium sulfate exposure, antenatal corticosteroid exposure, diagnosis of pre-eclampsia, chorioamnionitis (histopathologic diagnosis), arterial cord blood gas pH, and the five-minute Apgar score. Patient factors included estimated gestational age (EGA) in completed weeks, birth weight, intrauterine growth restriction status (defined as birth weight \<10^th^ centile), sex, and race/ethnicity. Clinical factors included CRIB-II score (using the algorithm developed by Parry et al.([@R19])), IVH (based on cranial ultrasound in the first week of life, graded using the Papile scoring system([@R20])), inotrope use in the first 72 hours of life (inclusive of dopamine, dobutamine, epinephrine, and norepinephrine), culture-positive sepsis, and mortality.

Institutional guidelines for the management of hypotension {#S9}
----------------------------------------------------------

For blood pressure support, our institutional practice is to consider inotrope initiation if (a) mean arterial blood pressure (MABP) \< EGA in weeks, (b) poor urine output (\< 1 mL/kg/h) and/or (c) clinical signs of poor perfusion (e.g. prolonged central capillary refill time \> 3 seconds or tachycardia). Dopamine is used as the first-line agent, with a starting dose between 2.5 and 5 mcg/kg/min. Epinephrine is used as an alternative first-line treatment (starting dose 0.05 mcg/kg/min) or as a second-line treatment when there is inadequate response to dopamine (when dosing exceeds 10 mcg/kg/min). Additionally, hydrocortisone, dosed at 1 mg/kg every 8 hours, can be added as an alternative second-line treatment for refractory hypotension. Volume resuscitation with normal saline (NS) solution or packed red blood cells (pRBC) can be given prior to or in conjunction with inotropic support and is administered in 10 mL/kg (NS) or 15 ml/kg (pRBC) aliquots.

Data acquisition {#S10}
----------------

All data was collected with a sampling rate of 1 Hz using a data acquisition program (CAS Medical Systems, Inc., Branford, CT) which integrated the NIRS, pulse oximetry, and blood pressure signals in a single, time synchronized file on a laptop computer.

### NIRS {#S11}

Cerebral tissue oxygen saturation (SctO~2~) was obtained using 4-wavelength (690nm, 780nm, 805nm and 850nm) near-infrared spectroscopy (FORE-SIGHT, CAS Medical Systems, Inc., Branford, CT) with a transducer containing a laser diode emitter and one optical detector located 25 mm from the light source. The non-adhesive optode was placed on the frontoparietal scalp, and recording was conducted over the first 72 hours after birth. Recordings were briefly interrupted every 12 hours to reposition the sensor medially or laterally to prevent skin bruising or breakdown.

### Pulse oximetry {#S12}

Pulse oximetry data (SpO~2~) were obtained using the Nellcor OxiMax algorithm integrated into the bedside patient monitor (Philips MP70 equipped with multi-measurement module M3001A-A04, Philips Healthcare, Andover, MA) using an adhesive probe placed on the hand or foot (Neonatal-Adult SpO~2~ Sensor, Covidien, Mansfield, MA).

### Blood pressure {#S13}

Per clinical practice, invasive umbilical blood pressure measurements are made using a pressure transducer (TruWave, Edwards Lifesciences, Irvine, CA), which interfaces the umbilical arterial catheter (3.5 Fr Argyle single lumen umbilical vessel catheter, Medtronic, Minneapolis, MN) with the patient monitor (IntelliVue MP70, Philips Medical, Andover, MA). Umbilical arterial catheters are placed in the "high-lying" position in the thoracic aorta, located between the sixth and eight vertebral body on chest radiograph. The mean arterial blood pressure was recorded at 1 Hz by taking the time-integrated mean of the beat-to-beat arterial blood pressure.

Data analysis {#S14}
-------------

### Pre-processing and error-correction {#S15}

Prior to calculation of FTOE-MABP pairs, the data underwent error correction using a modification of an algorithm developed previously ([@R13]). The SctO~2~ and SpO~2~ data streams were extracted from the source data file. Both data streams underwent multistep pre-processing to eliminate missing or invalid data. The data were partitioned into ten-minute epochs (600 serial, non- overlapping samples) and inspected for (i) interrupted regions of the recording (as noted in the research record), (ii) regions of the recording tagged by the NIRS or SpO~2~ device where it was not able properly measure saturations (e.g., probe not in contact with the skin), (iii) regions with sudden, non-physiologic changes in the baseline or excessive variance, based on the sliding-window motion artifact rejection algorithm proposed by Ayaz *et al*. ([@R21]). The entire data epoch was rejected if either data stream failed one or more of these checks or if continuous measurements were not available for both data sources throughout the entire epoch.

### FTOE by blood pressure calculation {#S16}

In order to examine the interaction between variation in blood pressure and developmentally-linked function of the cerebrovascular autoregulatory system, the fractional tissue oxygen (FTOE) was calculated for each 1-second sample for all remaining error-corrected ten-minute epochs of data using the standard equation: *FTOE = (SpO~2~-SctO~2~)/SpO~2~* ([@R22]). Values of FTOE were then sorted by the corresponding mean MABP in increments of 1 mmHg, calculated during the same 10-min epoch, and stored in a matrix. After calculations for all included infants were complete, the mean FTOE, at each measured value of MABP, was then calculated by gestational age group.

### Statistical approach {#S17}

Univariate comparisons of the sample characteristics were made between the more preterm group (23--25 weeks) and the more mature group (26--28 weeks) using the Mann--Whitney U-test for continuous variables or Fisher's Exact Test (two-sided) for categorical variables. The median FTOE was compared between three blood pressure states: low, medium and high. Normative data suggests most preterm infants have a MABP between 30 and 40 mmHg during the first 72 hours of life ([@R23],[@R24]). Additionally, a number of studies support 30 mmHg as the lower limit of autoregulatory control ([@R8],[@R25]--[@R27]), and 40--45 mmHg as the upper limit ([@R28],[@R29]). Using the existing literature as a guidepost, the blood pressure groups were defined empirically based on the interquartile distribution of blood pressures within each gestational age group. Comparison was made using Wilcoxon rank sum test. Given the novel nature of the analytic method, *a priori* sample size calculation was not performed, rather this was a convenience sample recruited over the three-year study period. Statistical comparisons were made using R version 3.3.2 (The R Foundation for Statistical Computing, Vienna, Austria).

RESULTS {#S18}
=======

Sample characteristics {#S19}
----------------------

A total of 68 infants were recruited with a mean±SD EGA of 25.4±1.3 weeks and mean±SD birth weight of 827.1±193.7 grams. In general, the two EGA groups (23--25 weeks, 26--28 weeks) were roughly equal in size (n=36 vs n=32) and were comparable across most clinical characteristics, with the expected exceptions of mean EGA (24.4 vs. 26.6 weeks, p\<0.01), mean birth weight (742.5 vs 922.3 grams, p\<0.01), and median CRIB-II score (13 vs. 10, p\<0.01). A complete listing of the characteristics by groups is shown in [Table 1](#T1){ref-type="table"}.

Hemodynamic characteristics {#S20}
---------------------------

A total of 1.1 million MABP values were captured with a sample median MABP of 35 mmHg and interquartile range of 31--40 mmHg. The median blood pressure value in the less mature group was slightly lower than the more mature group (32 vs 35 mmHg) and had lower bounds of distribution with an interquartile range of 29--36 vs. 32--39 mmHg, which closely match *a priori* expectations. The distribution of blood pressures between groups in shown in [Figure 1](#F1){ref-type="fig"}. There was no statistically significant difference in inotrope use between the two groups (33% vs. 22%, p=0.42). Inotropic support was started at a median blood pressure of 23 mmHg, with a range between 16 and 28 mmHg.

Data quality {#S21}
------------

Data collection was started at a mean±SD postnatal age of 17.8±9.7 hours with a mean±SD length of 40.2±13.5 hours. A total of 48.5% of data epochs were rejected owing to one or more error conditions. Approximately 39% of rejections were due to erroneous/missing blood pressure values, 59% of rejections due to erroneous/missing NIRS measurements, and 2% due to motion artifact. Data rejection occurred at equivalent rates between the two groups, with 50.9% of rejections occurring in the more preterm group and 49.1% in the more mature group. None of the infants had missing data due to removal of arterial catheter before the end of the study period.

FTOE and blood pressure {#S22}
-----------------------

Using the empirically defined values, the low, medium, and high MABP thresholds were \<29, 29--36, and \>36 mmHg for the more preterm group and \<32, 32--39, and \>39 mmHg for the more mature group. The median FTOE in the more preterm group vs. more mature group was statistically different in the low (0.218 vs. 0.267, p\<0.01) and the high (0.270 vs. 0.241, p=0.01) MABP range, but not the medium range (0.243 vs. 0.250, p=0.55). This differential response is shown graphically in [Figure 2](#F2){ref-type="fig"}, with a steady increase in FTOE as MABP decreases in the more mature group while the more preterm group had a paradoxical decrease in FTOE with decreasing MABP. Although small sample sizes contribute to wide error bars, this pattern is also apparent when EGA is treated as a continuous variable ([Figure 3](#F3){ref-type="fig"}).

DISCUSSION {#S23}
==========

These results suggest a developmentally-linked, metabolically-driven differential response in cerebral oxygen extraction to low and high blood pressures, which may reflect impaired autoregulation. The more mature group (GA 26--28 weeks) displayed an appropriate increase in oxygen extraction when the blood pressure dropped below 30 mmHg, a plateau across a range of medium blood pressures, and a gradual decrease as the MABP exceeds 40 mmHg. This matches the expectation that metabolically-driven autoregulation will cause oxygen extraction to increase during periods of decreased cerebral blood flow (hypotension) and decrease during periods of increased cerebral blood flow (hypertension) in order to maintain adequate oxygen delivery for cellular function. An opposite response was noted in the more preterm group (GA 23--26 weeks), with a paradoxical decrease in oxygen extraction, despite decreased cerebral blood flow (hypotension), potentially an indicator of cellular injury due to ischemia.

The difference in oxygen extraction between the two groups is limited to the extremes of blood pressure; both groups maintained FTOE values within the 80^th^ centile values for gestational age ([@R22]) when the blood pressure was between 30 and 40 mmHg. This finding suggests that the mechanisms which govern blood flow are unable to mount a compensatory response outside the range of medium blood pressures in the most preterm of infants.

Although the data from this study do not provide an answer as to the underlying mechanism which explains this differential response, other literature may offer some insights. During periods of low blood pressure, when cerebral tissue becomes ischemic, vasoactive compounds (including H^+^, K^+^, O^+^, NO, and adenosine) are released from the tissue, triggering local vasodilation ([@R16],[@R18],[@R30]). As cellular ionic gradients are not fully established in early development ([@R12]), it is reasonable to speculate that this may contribute to a diminished response as compared to the more mature infants. Similarly, vascular control at high blood pressures is largely regulated through the myogenic response ([@R16]), a factor which has a known association with maturation ([@R31]).

As previously noted, hypoxic-ischemic injury to the germinal matrix is one potential mechanism behind the genesis of intraventricular hemorrhage. This study highlights the apparent inability of the preterm brain to compensate accordingly to hypotension, generating the circumstances in which IVH might result. This finding potential implications for clinical management, suggesting that aggressive treatment of hypotension may not be indicated in more mature infants with a more functional autoregulatory system. In contrast, conservative management of blood pressure in the most premature of infants carries the real risk of exacerbating the brain injury from ischemia and a more proactive management strategy might be indicated to push the blood pressure higher, and thus cerebral blood flow back into the range of values which support adequate oxygen delivery for cerebral metabolism.

This study has several important caveats. Primarily, the small sample size precludes broad generalization of the findings in a larger population. Study of this phenomena in a larger sample is needed to confirm the results and to study the developmental effects on a more granular level. Second, the approach to error correction in this study was intentionally conservative, excluding data frames with potentially problematic areas. Future studies should investigate the tolerance of algorithms for data containing a greater degree of noise. Third, as the pulse-oximetry probe location is rotated every twelve hours, in order to protect skin integrity in the fragile preterm infant, the pulse oximetry data represents a composite of both pre- and post-ductal saturation, which may have slightly altered the FTOE values. Fourth, the observational study design did not allow for strict control of clinical parameters. Fifth, not surprisingly, there were small differences between the cohort (beyond the intentional EGA grouping) particularly pCO2, a factor which is an important contributor to autoregulatory function. However, the difference between groups (49.9 vs. 43.7 mmHg), while statistically significant, is not clinically significant, as both values are within the acceptable range for a preterm infant. Sixth, while the blood pressure thresholds were empirically derived, it is possible, and indeed likely, that these thresholds are variable by week of gestation at birth. Study of this phenomena in a larger sample size will permit the use of distinct BP thresholds by gestational age and further exploration of gestational age as a continuous variable. Finally, while the findings of this present study suggest that the autoregulatory systems of very preterm infants lack the ability to compensate for hypotension by increasing oxygen extraction, this state only implies an increased risk for injury, not the absolute certainty of it. Extensive clinical validation should be performed to better ascertain the predictive value of this metric.

In summary, using continuous multi-modality recording, the metabolically-driven response of the preterm brain to low, medium, and high blood pressure values can be measured. More mature infants, those between 26 and 28 weeks, demonstrate the expected response, increasing extraction at low blood pressure values and decreasing extraction at high values. More preterm infants, those between 23 and 25 weeks demonstrated the opposite response, providing further evidence that autoregulatory immaturity is a potential risk factor for brain injury by depriving the cerebral tissue of oxygen during the greatest period of demand.
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![Histogram of MABP values record in the two groups. The less mature group is shown with black bars, the more mature group with white bars. Overlap between groups is shown in gray.](nihms898420f1){#F1}

![Blood pressure vs. FTOE is shown for both groups (solid line - 23--25 weeks, dashed line - 26--28 weeks). Blood pressure group is defined by color with low MABP in red, medium in blue, and high in green. Note the increase in FTOE during hypotension for the more mature infants, suggestive of a metabolically-driven autoregulatory response. In contrast, the more preterm group has a paradoxical drop in FTOE, suggesting immaturity of metabolically driven autoregulation. Whiskers represent ±1 SEM.](nihms898420f2){#F2}

![Blood pressure vs. FTOE by individual EGA groups. The more premature group is shown in blue (solid blue=23 weeks, dashed blue=24 weeks, dotted blue=25 weeks) and the more mature group shown in red (solid red=26 weeks, dashed red=27 weeks, dotted red=28 weeks). Whiskers represent ±1 SEM.](nihms898420f3){#F3}

###### 

Sample characteristics

  --------------------------------------------------------------------------------------------------------------
                                         More preterm (23--25 weeks)\   More mature (26--28 weeks)\   P value
                                         N=36                           N=32                          
  -------------------------------------- ------------------------------ ----------------------------- ----------
  EGA, mean (SD), weeks                  24.4 (0.6)                     26.6 (0.8)                    \<0.01\*

  Birth weight, mean (SD), grams         743 (133)                      922 (208)                     \<0.01\*

  IUGR, n (%)                            2 (6)                          4 (13)                        0.41

  Male sex, n (%)                        25 (69)                        21 (66)                       0.79

  Antenatal steroids                                                                                  

   Any, n (%)                            26 (72)                        26 (81)                       0.41

   Complete course, n (%)                20 (56)                        13 (41)                       0.24

  Antenatal magnesium sulfate, n (%)     12 (33)                        18 (56)                       0.09

  Pre-eclampsia, n (%)                   2 (6)                          3 (9)                         0.66

  Vaginal delivery, n (%)                13 (36)                        12 (38)                       1.00

  Chorioamnionitis, n (%)                12 (33)                        11 (34)                       1.00

  Apgar score at 5 min, median (range)   6 (1--8)                       6 (1--9)                      0.49

  CRIB-II score, median (range)          13 (10--16)                    10 (6--14)                    \<0.01\*

  Inotrope use in first 72h, n (%)       12 (33)                        7 (22)                        0.42

  Median MABP in first 72h, (IQR)        32 (29--36)                    35 (32--39)                   0.01\*

  Fentanyl use in first 72h, n (%)       13 (36)                        19 (59)                       0.09

  pCO~2~ in first 72h, mean (SD), mmHg   49.9 (11.2)                    43.7 (8.4)                    0.01\*

  IVH                                                                                                 

   Any grade, n (%)                      14 (39)                        9 (28)                        0.44

   Grade III/IV, n (%)                   4 (11)                         2 (6)                         0.67

  Died, n (%)                            5 (14)                         1 (3)                         0.20
  --------------------------------------------------------------------------------------------------------------
